slide 1

Back to the List of the Granted Patents                                                Click here to download AP2694 PDF

(11)    Patent No :    AP 2695   
(21)    Application No :    AP/P/2008/004362   
(22)    Filing Date :    21.04.2006   
(24)    Date of Grant &    16.07.2013   
           
(45)    Publication :

(30)  Priority Data       
(33) Country    (31) Number    (32) Date
IN    505/MUM/2005    25.04.2005
(84)    Designated State

BW    GM    GH    KE    LS    MW  MZ   NA   SL
SD    SZ    T Z    UG    ZM    ZW
(73) Applicant(s)
"CADILA PHARMACEUTICALS LIMITED", Cadila Corporate
Campus, Sarkhej- Dholka Road, Bhat, Ahmedabad 382 210
Gujarat,
India
(72) Inventors

DESAI Nirav, India

GHOSH Prasanta Kumar, India

KHAMAR Bakulesh Mafatlal, India

et a
(74) Representative
GLLOWAY & COMPANY
ZIMBABWE
(51)  International  Classification   A61K 39/39 (2006.01)    C12N 1/20 (2006.01)
(54)    Title

Vaccine adjuvants.

(57)    Abstract

The invention relates, to a novel adjuvant Mycobacterium w and or its constituents and adjuvant containing composition, which contains antigen (s) with pharmaceutical acceptable carrier and its uses. Mycobacterium w and or its constituents when administered with antigen (s) to mammal results in enhanced immunogenicity of antigen. The enhanced immunogenicity manifests as humoral responses as well as cell mediated immunity. The adjuvant effect is seen with variety of antigens in various mammals irrespective of their immune status at the time of administration of Mycobacterium w and antigen containing composition, e.g. immune naEve or preimmunised status.

(56)    Documents Cited :    WO 03/049667    PETROVSKY N    WO 03/075825    GORMUS BOBBY J et al:    STILL

HAROLD

Newsletter

Join our newsletter for CIPIT news through subscriptions!

SEND

Social Media

 

    

Contact Us

TEL : (254) 703 034 612